[Clinical evaluation of cefuzonam for bacterial pneumonia].
Ten patients with moderate or severe bacterial pneumonia with underlying diseases or complications were treated with cefuzonam (CZON) at a daily dose of 2 g to 4 g. The clinical effectiveness was good in 9 patients. No side effects or abnormal laboratory test results were observed in any patient. These results suggest that CZON may be useful in the treatment of bacterial pneumonia.
Mikasa
K
K
Second Department of Internal Medicine, Nara Medical University.
Sawaki
M
M
Konishi
M
M
Kunimatsu
M
M
Hamada
K
K
Takeuchi
S
S
Maeda
K
K
Narita
N
N
D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000188:drug therapy*; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*
C049934:cefuzonam; D015296:Ceftizoxime